-
Zelensky stops in Canada en route to US as Russia pummels Ukraine
-
Arteta salutes injury-hit Arsenal's survival spirit
-
Wirtz scores first Liverpool goal as Anfield remembers Jota
-
Mane rescues AFCON draw for Senegal against DR Congo
-
Arsenal hold off surging Man City, Wirtz breaks Liverpool duck
-
Arsenal ignore injury woes to retain top spot with win over Brighton
-
Sealed with a kiss: Guardiola revels in Cherki starring role
-
UK launches paid military gap-year scheme amid recruitment struggles
-
Jota's children join tributes as Liverpool, Wolves pay respects
-
'Tired' Inoue beats Picasso by unanimous decision to end gruelling year
-
Thailand and Cambodia declare truce after weeks of clashes
-
Netanyahu to meet Trump in US on Monday
-
US strikes targeted IS militants, Lakurawa jihadists, Nigeria says
-
Cherki stars in Man City win at Forest
-
Schwarz records maiden super-G success, Odermatt fourth
-
Russia pummels Kyiv ahead of Zelensky's US visit
-
Smith laments lack of runs after first Ashes home Test loss for 15 years
-
Russian barrage on Kyiv kills one, leaves hundreds of thousands without power
-
Stokes, Smith agree two-day Tests not a good look after MCG carnage
-
Stokes hails under-fire England's courage in 'really special' Test win
-
What they said as England win 4th Ashes Test - reaction
-
Hong Kongers bid farewell to 'king of umbrellas'
-
England snap 15-year losing streak to win chaotic 4th Ashes Test
-
Thailand and Cambodia agree to 'immediate' ceasefire
-
Closing 10-0 run lifts Bulls over 76ers while Pistons fall
-
England 77-2 at tea, need 98 more to win chaotic 4th Ashes Test
-
Somalia, African nations denounce Israeli recognition of Somaliland
-
England need 175 to win chaotic 4th Ashes Test
-
Cricket Australia boss says short Tests 'bad for business' after MCG carnage
-
Russia lashes out at Zelensky ahead of new Trump talks on Ukraine plan
-
Six Australia wickets fall as England fight back in 4th Ashes Test
-
Dental Implant Financing and Insurance Options in Georgetown, TX
-
Man Utd made to 'suffer' for Newcastle win, says Amorim
-
Morocco made to wait for Cup of Nations knockout place after Egypt advance
-
Key NFL week has playoff spots, byes and seeds at stake
-
Morocco forced to wait for AFCON knockout place after Mali draw
-
Dorgu delivers winner for depleted Man Utd against Newcastle
-
US stocks edge lower from records as precious metals surge
-
Somalia denounces Israeli recognition of Somaliland
-
The Cure guitarist and keyboard player Perry Bamonte dies aged 65
-
Draper to miss Australian Open
-
Police arrest suspect after man stabs 3 women in Paris metro
-
Former Montpellier coach Gasset dies at 72
-
Trump's Christmas gospel: bombs, blessings and blame
-
Russia lashes out at Zelensky ahead of new Trump meeting on Ukraine plan
-
Salah helps Egypt beat South Africa and book last-16 place
-
Australia's Ikitau facing lengthy lay-off after shoulder injury
-
Another 1,100 refugees cross into Mauritania from Mali: UN
-
Guardiola proud of Man City players' response to weighty issues
-
Deadly blast hits mosque in Alawite area of Syria's Homs
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
P.Martin--AMWN